Description
IODOSORB
CE medical device. Antiseptic dressing based on cadexomer technology: absorbs exudates and releases iodine in a controlled manner.Indicated for the local treatment of chronic exuding wounds. IODOSORB can be used under compression therapy. IODOSORB can be used on infected wounds. When the product is used on infected wounds.
How to use
Application
Wash your hands thoroughly before and after application. After donning gloves, clean the wound and the surrounding area with a gentle stream of water or saline. Do not dry the wound surface. Remove the impregnated gauze from both sides of the single-dose paste or open the packaging (pouch or aluminum tube). Conform the dressing to the wound surface. Cover the wound completely with an appropriate secondary dressing. Apply a compression bandage, where indicated.
Change
IODOSORB should be changed when it is saturated with exudate and has released all the iodine. This is indicated by discoloration, usually two or three times a week. If the wound is very exudative, it may be necessary to change the dressing every day. If necessary, wet the residue for a few minutes before removing it. Gently remove IODOSORB using a jet of water or saline. Before reapplying IODOSORB, gently absorb any excess fluid, leaving the wound surface slightly moist.
Warnings
There is a potential risk of interaction with lithium, resulting in an increased likelihood of hypothyroidism. Do not use IODOSORB concomitantly with mercurial antiseptics or taurolidine. Consider possible interference with thyroid function indices in case of diagnostic thyroid tests.
Contraindications
IODOSORB should not be used on dry necrosis, nor in patients with known hypersensitivity to iodine or to one of its components. Do not use IODOSORB in pediatric age, during pregnancy or breastfeeding, or in people with thyroid or renal function disorders (for example Hashimoto's thyroiditis or non-toxic nodular goiter).
Precautions for use
The contents of the single pack are for single patient use only. Do not use IODOSORB near the eyes, ears, nose or mouth. The product is for external use only. In the first hour after application, IODOSORB may cause mild and transient pain. This indicates that the product is starting to cleanse the wound. Occasionally, IODOSORB may cause swelling or redness of the periwound skin. This effect is usually transitory. Contact of the product with the periwound skin or with intact skin should be minimized. When IODOSORB is allowed to dry, an adherent crust may form.
Format
7 sachets of 3 g of microgranules.
Cod. 66001286
